Clinical Trials on High-Risk and Very High-Risk Myelodysplastic Syndromes

Total 1153 results

Array BioPharma

Completed

A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors

AML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDS

United States, Australia, Italy, Spain, France, Switzerland, United Kingdom
Schrödinger, Inc.

Terminated

Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Acute Myeloid Leukemia | High-Risk and Very High-Risk Myelodysplastic Syndromes

United States
Ciusss de L'Est de l'Île de Montréal
Stem Cell Network

Recruiting

A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe. (ECT-001-CB-013)

Acute Leukemia, High Risk | Myelodysplastic Syndromes, High Risk | Hematologic Malignancy Requiring an Allogeneic Hematopoietic Stem Cell Transplant Lacking a Donor

Canada
First Affiliated Hospital of Zhejiang University
Tongji Hospital; Ruijin Hospital; The First Affiliated Hospital of Zhengzhou... and other collaborators

Recruiting

Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study) (Ven-BUCY)

Acute Myeloid Leukemia | Myelodysplastic Syndromes | High-Risk Acute Myeloid Leukemia | High-Risk Myelodysplastic Syndromes

China
Virginia Commonwealth University

Not yet recruiting

Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN

High Risk Myelodysplastic Syndrome | Relapsed / Refractory AML | High Risk Myeloproliferative Neoplasms

United States

Clinical Trials on High-Risk and Very High-Risk Myelodysplastic Syndromes

This is a preview